{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:37:03Z","timestamp":1782139023094,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17lk0310036"],"award-info":[{"award-number":["JP17lk0310036"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18lk0310049"],"award-info":[{"award-number":["JP18lk0310049"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19lk0310064"],"award-info":[{"award-number":["JP19lk0310064"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00204-019-02588-2","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T07:11:37Z","timestamp":1570777897000},"page":"3111-3119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study"],"prefix":"10.1007","volume":"93","author":[{"given":"Kanon","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-1926","authenticated-orcid":false,"given":"Tetsuhiro","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-7592","authenticated-orcid":false,"given":"Kan\u2019ichiro","family":"Ishiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1047-7999","authenticated-orcid":false,"given":"Takao","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-0646","authenticated-orcid":false,"given":"Keiko","family":"Ogawa-Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Minamizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2524-8745","authenticated-orcid":false,"given":"Toshiaki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-5897","authenticated-orcid":false,"given":"Tomonori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3874-5273","authenticated-orcid":false,"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5823-6441","authenticated-orcid":false,"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"2588_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1248\/cpb.35.705","volume":"35","author":"T Akao","year":"1987","unstructured":"Akao T, Akao T, Kobashi K (1987) Glycyrrhizin \u03b2-d-glucuronidase of Eubacterium sp. from human intestinal flora. Chem Pharm Bull 35:705\u2013710. \n                    https:\/\/doi.org\/10.1248\/cpb.35.705","journal-title":"Chem Pharm Bull"},{"key":"2588_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.2042-7158.1994.tb03756.x","volume":"46","author":"T Akao","year":"1994","unstructured":"Akao T, Hayashi T, Kobashi K, Kanaoka M, Kato H, Kobayashi M, Takeda S, Oyama T (1994) Intestinal bacterial hydrolysis is indispensable to absorption of 18\u03b2-glycyrrhetic acid after oral administration of glycyrrhizin in rats. J Pharm Pharmacol 46:135\u2013137. \n                    https:\/\/doi.org\/10.1111\/j.2042-7158.1994.tb03756.x","journal-title":"J Pharm Pharmacol"},{"key":"2588_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mce.2010.12.011","volume":"336","author":"EAS Al-Dujaili","year":"2011","unstructured":"Al-Dujaili EAS, Kenyon CJ, Nicol MR, Mason JI (2011) Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity. Mol Cell Endocrinol 336:102\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.mce.2010.12.011","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2588_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/jama.1968.03140330034006","volume":"205","author":"JW Conn","year":"1968","unstructured":"Conn JW, Rovner DR, Cohen EL (1968) Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA 205(7):492\u2013496. \n                    https:\/\/doi.org\/10.1001\/jama.1968.03140330034006","journal-title":"JAMA"},{"issue":"Pt A","key":"2588_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2016.05.005","volume":"259","author":"MWH Coughtrie","year":"2016","unstructured":"Coughtrie MWH (2016) Function and organization of the human cytosolic sulfotransferase (SULT) family. Chem Biol Interact 259(Pt A):2\u20137. \n                    https:\/\/doi.org\/10.1016\/j.cbi.2016.05.005","journal-title":"Chem Biol Interact"},{"issue":"3","key":"2588_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yrtph.2006.06.002","volume":"46","author":"RA Isbrucker","year":"2006","unstructured":"Isbrucker RA, Burdock GA (2006) Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 46(3):167\u2013192. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2006.06.002","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"2588_CR7","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41598-018-38182-2","volume":"9","author":"K Ishiuchi","year":"2019","unstructured":"Ishiuchi K, Morinaga O, Ohkita T, Tian C, Hirasawa A, Mitamura M, Maki Y, Kondo T, Yasujima T, Yuasa H, Minamizawa K, Namiki T, Makino T (2019) 18\u03b2-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism. Sci Rep 9(1):1587. \n                    https:\/\/doi.org\/10.1038\/s41598-018-38182-2","journal-title":"Sci Rep"},{"issue":"1","key":"2588_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/00498257109044381","volume":"1","author":"P Iveson","year":"1971","unstructured":"Iveson P, Lindup WE, Parke DV, Williams RT (1971) The metabolism of carbenoxolone in the rat. Xenobiotica 1(1):79\u201395. \n                    https:\/\/doi.org\/10.3109\/00498257109044381","journal-title":"Xenobiotica"},{"issue":"6","key":"2588_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jcem.80.6.7775643","volume":"80","author":"H Kato","year":"1995","unstructured":"Kato H, Kanaoka M, Yano S, Kobayashi M (1995) 3-Monoglucuronyl-glycyrrhetinic acid is a major metabolite that causes licorice-induced pseudoaldosteronism. J Clin Endocrinol Metab 80(6):1929\u20131933. \n                    https:\/\/doi.org\/10.1210\/jcem.80.6.7775643","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2588_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1248\/bpb.22.320","volume":"22","author":"DH Kim","year":"1999","unstructured":"Kim DH, Lee SW, Han MJ (1999) Biotransformation of glycyrrhizin to 18\u03b2-glycyrrhetinic acid-3-O-\u03b2-D-glucuronide by Streptococcus LJ-22, a human intestinal bacterium. Biol Pharm Bull 22(3):320\u2013322. \n                    https:\/\/doi.org\/10.1248\/bpb.22.320","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"2588_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/BF02975509","volume":"23","author":"DH Kim","year":"2000","unstructured":"Kim DH, Hong SW, Kim BT, Bae EA, Park HY, Han MJ (2000) Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities. Arch Pharm Res 23(2):172\u2013177. \n                    https:\/\/doi.org\/10.1007\/BF02975509","journal-title":"Arch Pharm Res"},{"issue":"5","key":"2588_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bcpt.13178","volume":"124","author":"A Komatsu","year":"2019","unstructured":"Komatsu A, Yoshino T, Suzuki T, Nakamura T, Kanai T, Watanabe K (2019) Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: a retrospective cohort study. Basic Clin Pharmacol Toxicol 124(5):607\u2013614. \n                    https:\/\/doi.org\/10.1111\/bcpt.13178","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2588_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1124\/jpet.111.190009","volume":"342","author":"T Makino","year":"2012","unstructured":"Makino T, Okajima K, Uebayashi R, Ohtake N, Inoue K, Mizukami H (2012) J Pharmacol Exp Ther 342(2):297\u2013304. \n                    https:\/\/doi.org\/10.1124\/jpet.111.190009","journal-title":"J Pharmacol Exp Ther"},{"issue":"4\u20135","key":"2588_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-0760(01)00064-4","volume":"77","author":"AC Meloche","year":"2001","unstructured":"Meloche AC, Falany NC (2001) Expression and characterization of the human 3\u03b2-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b). J Steroid Biochem Mol Biol 77(4\u20135):261\u2013269. \n                    https:\/\/doi.org\/10.1016\/S0960-0760(01)00064-4","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2588_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tiv.2005.06.048","volume":"20","author":"YJ Moon","year":"2006","unstructured":"Moon YJ, Wang X, Morris ME (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20(2):187\u2013210. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2005.06.048","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2588_CR16","doi-asserted-by":"publisher","first-page":"15568","DOI":"10.1038\/s41598-018-33834-9","volume":"8","author":"O Morinaga","year":"2018","unstructured":"Morinaga O, Ishiuchi K, Ohkita T, Tian C, Hirasawa A, Mitamura M, Maki Y, Yasujima T, Yuasa H, Makino T (2018) Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism. Sci Rep 8(1):15568. \n                    https:\/\/doi.org\/10.1038\/s41598-018-33834-9","journal-title":"Sci Rep"},{"key":"2588_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","volume":"45","author":"M Palermo","year":"1996","unstructured":"Palermo M, Shackleton CHL, Mantero F, Stewart PM (1996) Urinary free cortisone and the assessment of 11\u03b2-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 45:605\u2013611. \n                    https:\/\/doi.org\/10.1046\/j.1365-2265.1996.00853.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2588_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/taap.2000.907","volume":"170","author":"B Ploeger","year":"2001","unstructured":"Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J (2001) population physiologically based pharmacokinetic\/pharmacodynamic model for the inhibition of 11-\u03b2-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicol Appl Pharmacol 170(1):46\u201355. \n                    https:\/\/doi.org\/10.1006\/taap.2000.907","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"2588_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40292-016-0160-5","volume":"23","author":"C Sabbadin","year":"2016","unstructured":"Sabbadin C, Armanini D (2016) Syndromes that mimic an excess of mineralocorticoids. High Blood Press Cardiovasc Prev 23(3):231\u2013235. \n                    https:\/\/doi.org\/10.1007\/s40292-016-0160-5","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"11","key":"2588_CR20","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1002\/jps.24596","volume":"104","author":"C Sadakane","year":"2015","unstructured":"Sadakane C, Watanabe J, Fukutake M, Nishimura H, Maemura K, Kase Y, Kono K (2015) Pharmacokinetic profiles of active components after oral administration of a kampo medicine, Shakuyakukanzoto, to healthy adult Japanese volunteers. J Pharm Sci 104(11):3952\u20133959. \n                    https:\/\/doi.org\/10.1002\/jps.24596","journal-title":"J Pharm Sci"},{"issue":"8563","key":"2588_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","volume":"2","author":"PM Stewart","year":"1987","unstructured":"Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW (1987) Mineralocorticoid activity of liquorice: 11\u03b2-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2(8563):821\u2013824. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(87)91014-2","journal-title":"Lancet"},{"key":"2588_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0960-0760(02)00033-X","volume":"80","author":"T Tanahashi","year":"2002","unstructured":"Tanahashi T, Mune T, Morita H, Tanahashi H, Isomura Y, Suwa T, Daido H, Gomez-Sanchez CE, Yasuda K (2002) Glycyrrhizic acid suppresses type 2 11\u03b2-hydroxysteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biol 80:441\u2013447. \n                    https:\/\/doi.org\/10.1016\/S0960-0760(02)00033-X","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2588_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.apsb.2018.07.007","volume":"8","author":"X Tian","year":"2018","unstructured":"Tian X, Chao W, Peipei D, Yue A, Xinyu Z, Weiru J, Gang W, Jie H, Lei F, Yan W, Guangbo G, Xiaokui H, Jing N, Xiaochi M (2018) Arenobufagin is a novel isoform-specific probe forsensing human sulfotransferase 2A1. Acta Pharm Sinica B 8(5):784\u2013794. \n                    https:\/\/doi.org\/10.1016\/j.apsb.2018.07.007","journal-title":"Acta Pharm Sinica B"},{"key":"2588_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0889-8529(18)30102-6","volume":"23","author":"BR Walker","year":"1994","unstructured":"Walker BR, Edwards CR (1994) Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin N Am 23:359\u2013377. \n                    https:\/\/doi.org\/10.1016\/S0889-8529(18)30102-6","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2588_CR25","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1210\/endo.132.6.8504732","volume":"132","author":"CB Whorwood","year":"1993","unstructured":"Whorwood CB, Sheppard MC, Stewart PM (1993) Licorice inhibits 11\u03b2-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132:2287\u20132292. \n                    https:\/\/doi.org\/10.1210\/endo.132.6.8504732","journal-title":"Endocrinology"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-019-02588-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T23:05:29Z","timestamp":1602284729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-019-02588-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2588"],"URL":"https:\/\/doi.org\/10.1007\/s00204-019-02588-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All registered participants provided written informed consent, and the study design was approved by the appropriate institutional review boards at Keio University, Chiba University, Kanazawa University, and Kameda Medical Center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}